You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TVTX Sale Disclosure
Dube Eric M · SEC Form 4 · Filed Oct 19, 2026
Sale
Calculated transaction value
$2.02M
Dube Eric M Chief Executive Officer
TVTX
Travere Therapeutics
TVTX
Transaction date
Oct 15, 2026
Public filing date
Oct 19, 2026
Filing lag
Filed 4 days later
TVTX daily price context
Close on/before transaction
$52.79
Oct 15, 2026
First close after public filing
$52.3
Oct 20, 2026
Return after filing · so far
-0.27%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 37,270 shares @ $54.2
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001763494-26-000008
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$16.08M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Travere Therapeutics, Inc. TVTX | Exercise | Oct 15, 2026 | $1.79M |
| Travere Therapeutics, Inc. TVTX | Sale | Oct 15, 2026 | $6.78M |
| Travere Therapeutics, Inc. TVTX Current | Sale | Oct 15, 2026 | $2.02M |
| Travere Therapeutics, Inc. TVTX | Sale | Oct 15, 2026 | $4.31M |
| Travere Therapeutics, Inc. TVTX | Exercise | Oct 15, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Oct 15, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Oct 15, 2026 | $1.18M |